ProfileGDS5822 / ILMN_2975382
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 31% 39% 38% 55% 57% 35% 28% 51% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.731
GSM1276600PDAC Late Ablation Control 22039
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 115.438
GSM1276603PDAC Late Ablation 226.555
GSM1276604PDAC Late Ablation 329.357
GSM1303940PDAC Late Ablation_anti-CTLA4 116.935
GSM1303941PDAC Late Ablation_anti-CTLA4 213.828
GSM1303942PDAC Late Ablation_anti-CTLA4 326.951